Taronis Fuels Schedules Shareholder Town Hall

CEO and CFO to Provide Business Update

PHOENIX, AZ, Jan. 04, 2021 (GLOBE NEWSWIRE) — Taronis Fuels, Inc., (“Taronis” or “the Company”) (OTCQB: TRNF), a global producer of renewable and socially responsible fuel products, today announced that the Company will hold a shareholder town hall on Monday, January 11, 2021 at 10 am ET. The executive team will provide a brief update on preliminary results of operations for 2020, as well as a financial outlook for the first half of 2021. To participate in the call, please use the following dial in information:

Event: Taronis Fuels Town Hall Conference Call
Date: Monday, January 11th
Time: 10:00am ET
Participant Dial-In (Toll-Free): 877-407-0989
Participant Dial-In International (Toll-Free): 201-389-0921
Webcast Link: https://www.webcast-eqs.com/taronis20210111/en
Conference ID: 13714644

About Taronis Fuels, Inc.

Taronis Fuels, Inc. is a global producer of renewable and socially responsible fuel products. Our goal is to deliver environmentally sustainable, technology driven alternatives to traditional fossil fuel and carbon-based economy products. We believe our products offer a vastly cleaner solution to legacy acetylene and propane alternatives.

Taronis is also dedicated to providing fundamentally safer solutions to meet the industrial, commercial and residential needs of tomorrow’s global economy. Our products have been rigorously tested and independently validated by global gas authorities as vastly safer than acetylene, the most dangerous industrial gas in use today.

Lastly, we strive to deliver products that offer significant function superiority at a reduced cost to the end consumer. Through these efforts, we support 9 of the 17 United Nations Sustainable Development Goals. For more information, please visit our website at www.taronisfuels.com/

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements relate to future events, including our ability to raise capital, or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For a discussion of these risks and uncertainties, please see our filings with the Securities and Exchange Commission. Our public filings with the SEC are available from commercial document retrieval services and at the website maintained by the SEC at http://www.sec.gov.

Investor Contacts:
Michael Khorassani
[email protected]



Virtas Partners Promotes Adam Alexander to Director

CHICAGO, Jan. 04, 2021 (GLOBE NEWSWIRE) — Adam Alexander has been promoted to Director at Virtas Partners, a boutique consulting firm helping clients successfully navigate key transitions, including acquisitions, divestitures, carve-outs, accounting investigations and restatements, restructurings, and capital placements.

Alexander focuses primarily on Financial Planning and Analysis (FP&A) advisory as well Quality of Earnings services for acquisitions and divestitures.

“Adam’s combination of technical expertise and excellent client service has earned him the confidence and trust of our clients,” said Virtas Partners co-founder and Managing Partner Neal McNamara. “He has been integral in expanding our abilities to support our clients across the entire finance organization.”  

Alexander has led multiple client engagements, ranging from projects requiring specific and detailed financial analysis to a mandate to create and build out an entire FP&A function (see this case study).

Co-founder and Managing Partner Tim Czmiel added: “Adam has earned this promotion through his dedication and exemplary work ethic. As Virtas Partners further grows in scale and client capabilities, we will continue to provide opportunities for career advancement for our people. Contribution to our winning culture within the Virtas family is key to our success individually and as a firm.”

Virtas Partners: Trusted. Proven. Our team aligned for your success. www.virtaspartners.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a544ea0d-671d-4d9c-8740-1bce8e8e024b



Contact:
Jon Harmon
[email protected]
(630) 815-6586

BIIB INVESTOR DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Biogen Inc.

PR Newswire

NEW YORK, Jan. 4, 2021 /PRNewswire/ — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB) from October 22, 2019 through November 6, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Central District of California alleges violations of the Securities Exchange Act of 1934.

If you purchased Biogen securities, and/or would like to discuss your legal rights and options please visit Biogen Shareholder Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected].

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the larger dataset did not provide necessary data regarding aducanumab’s effectiveness; (2) the EMERGE study did not and would not provide necessary data regarding aducanumab’s effectiveness; (3) the PRIME study did not and would not provide necessary data regarding aducanumab’s effectiveness; (4) the data provided by the Company to the FDA’s Peripheral and Central Nervous System Drug Advisory Committee did not support finding efficacy of aducanumab; and (5) as a result, Defendants’ statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On November 6, 2020, Reuters published an article entitled “U.S. FDA panel votes cannot ignore unsuccessful trial data on Biogen Alzheimer’s drug” which provided information regarding the FDA panel’s votes.

On this news, Biogen’s stock price fell $92.64 per share, or 28%, to close at $236.26 per share on November 9, 2020, the next trading day, damaging investors.

If you wish to serve as lead plaintiff, you must move the Court no later than January 12, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased Biogen securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/biogeninc-biib-shareholder-class-action-lawsuit-fraud-stock-332/apply/  or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected].

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero

Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biib-investor-deadline-bernstein-liebhard-llp-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-biogen-inc-301199854.html

SOURCE Bernstein Liebhard LLP

Shareholder Alert: Ademi LLP Investigates whether FLIR Systems, Inc. has obtained a Fair Price in its transaction with Teledyne

PR Newswire

MILWAUKEE, Jan. 4, 2021 /PRNewswire/ — Ademi LLP is investigating FLIR Systems (NASDAQ:FLIR) for possible breaches of fiduciary duty and other violations of the law in its transaction with Teledyne.

Click here to learn how to join the action: http://ademilaw.com/case/flir-systems-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.

Ademi LLP alleges FLIR Systems’ financial outlook is improving and yet FLIR Systems shareholders will receive only $28.00 per share in cash and 0.0718 shares of Teledyne common stock for each FLIR share, which implies a total purchase price of $56.00 per FLIR Systems share based on Teledyne’s 5-day volume weighted average price as of December 31, 2020.  The merger agreement unreasonably limits competing bids for FLIR Systems by prohibiting solicitation of further bids, and imposing a termination penalty if FLIR Systems accepts a superior bid. FLIR Systems insiders will receive millions of dollars as part of change of control arrangements. We are investigating the conduct of FLIR Systems’ board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for FLIR Systems.

If you own FLIR Systems common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or http://ademilaw.com/case/flir-systems-inc.                       

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

 

Cision View original content:http://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-flir-systems-inc-has-obtained-a-fair-price-in-its-transaction-with-teledyne-301200193.html

SOURCE Ademi LLP

Bolder Surgical launches CoolSeal™ Vessel Sealing Platform

Expanding Bolder Surgical’s line of vessel sealing products

LOUISVILLE, COLO., Jan. 04, 2021 (GLOBE NEWSWIRE) — Bolder Surgical, today announced the launch of its CoolSeal™ Vessel Sealing platform. 

Founded in 2010 as JustRight Surgical, Bolder Surgical provides surgeons right-sized surgical instruments to safely and effectively perform minimally invasive surgery in pediatric patients from neonate to teenager. With the launch of the CoolSeal Vessel Sealing platform, the company is leveraging proprietary low power technology to extend its vessel sealing product offering which is increasingly being adopted for use in larger patients.

Along with the new CoolSeal generator and 3mm CoolSeal Mini™ vessel sealer, the platform launch includes a new 5 mm laparoscopic vessel sealer, the CoolSeal Trinity™, a precise surgical instrument for general, urological and gynecological surgery.  “The 360-degree capability of CoolSeal Trinity’s fine-tipped, dual-action jaws allow for precise dissection and quick sealing times with minimal thermal distribution around important structures. It will be a nice addition to my repertoire of surgical instruments,” stated   Irving J. Zamora, MD, MPH, Monroe Carell Jr. Children’s Hospital at Vanderbilt.

In November 2019, Bolder Surgical acknowledged achievement of an important licensing and co-development milestone with Intuitive Surgical (NASDAQ: ISRG) that resulted in the recent market launch of Intuitive’s E100 vessel sealing generator. 

With the launch of the CoolSeal platform and the Intuitive Surgical co-development milestone completed, Bolder Surgical continues on its path of innovation. “Our focused investment in R&D will enable us to achieve the Company’s long-term vision of entering into markets that move beyond neonatal care.  We are excited about these launches and the robustness of our pipeline to come,” stated Robert Kline, President and CEO, Bolder Surgical

About Bolder Surgical

Bolder Surgical™ was founded with the mission to elevate surgical expectations. Leveraging an expertise in low power energy delivery and precision surgical devices, the company innovates to give surgeons options they’ve never had, optimizing workflow while allowing for minimal surgical impact on every patient. Bolder Surgical is the first and only company to acquire FDA clearance for a 3 mm pediatric vessel sealer, and its mechanical stapler is the only 5 mm stapler on the market.  Bolder Surgical’s products have been adopted at hundreds of hospitals throughout the world.



Donna Ford-Serbu
Bolder Surgical
719 246 9244
[email protected]

SHAREHOLDER ALERT: Lowey Dannenberg, P.C., Investigates Claims on Behalf of Investors of OrthoPediatrics Corp. (KIDS) and Encourages Investors to Contact the Firm

NEW YORK, Jan. 04, 2021 (GLOBE NEWSWIRE) — Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating claims of violations of federal securities laws on behalf of investors of OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS).

OrthoPediatrics operates as a medical device company. The Company designs, develops, and commercializes orthopaedic implants and instruments to improve the lives of children with orthopaedic conditions.

On December 2, 2020, Culper Research (“Culper”) published a report entitled “OrthoPediatrics Corp. (KIDS): Even Channel Stuffing Can’t Save This Company.” The Culper report described OrthoPediatrics as having “engaged in a channel stuffing scheme that has systematically and significantly overstated revenues.” Among other issues, the Culper report alleged that “the Company has abused its ability to book revenues upon shipment by selling and shipping excess product directly to its distributors, many of whom are exclusive to the Company” and described it as “concerning that many of the Company’s ‘exclusive distributors’ are simply former OrthoPediatrics employees who have formed their own distributorships, often while still employed at the Company.”

On this news, OrthoPediatrics’ stock price fell from $44.75 per share, or over 12%, to close at $39.35 per share on December 3, 2020.

On December 14, 2020, Culper published on a follow up report in which it concluded that OrthoPediatrics “is a structurally broken business which has relied on nefarious tactics to inflate its reported revenues.”

On this news, OrthoPediatrics’ stock price fell from $44.30 per share to $43.10, or 2.7%, during intraday trading on December 14, 2020.

If you are a shareholder of OrthoPediatrics and wish to participate, learn more, or discuss the issues surrounding the investigation, please contact our attorneys at (914) 733-7256 or via email at [email protected].

Whistleblowers: Persons with non-public information regarding OrthoPediatrics should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

Contact

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100 
White Plains, NY 10601
Tel: (914) 733-7256
Email: [email protected]



Jif® Brand Set to Expand Product Innovation and Convenience with Jif Natural Squeeze Creamy Peanut Butter Spread

The same Jif Natural Creamy Peanut Butter Spread fans know and love will soon be available in an easy-to-squeeze pouch

PR Newswire

ORRVILLE, Ohio, Jan. 4, 2021 /PRNewswire/ — The Jif® Brand today announced plans to launch its latest innovation with Jif® Natural Squeeze Creamy Peanut Butter Spread, which will be available online and at select retailers starting this month. The new product is easy to use for the whole family and can conveniently measure out the perfect portion of peanut butter for recipes, cookies and smoothies or be enjoyed right from the pouch on apples, celery or carrots.

Made with just five ingredients and 90 percent peanuts, Jif Natural Squeeze Creamy Peanut Butter Spread contains no preservatives or GMOs.  

“We’re excited to expand our innovative Jif Squeeze product line, giving Jif peanut butter lovers more ways to enjoy,” said Jake Calhoun, Director of Brand Strategy for the Jif Brand. “Now you can get the last ounce of squeezable, creamy goodness in an additional variation – because it’s That Jif’ing Good!”

Jif Natural Squeeze Creamy Peanut Butter Spread is a convenient multi-serve 13 oz. pouch, making it the perfect pantry staple for snacking for everyone in the family, even the kids. The new product will be included in the “Gladiator” commercial, which is also launching nationally today. The campaign includes 15, 30 and 60 second ad spots that highlight how the peanut butter can be enjoyed without the use of a spoon.

About The J.M. Smucker Co.

Each generation of consumers leaves their mark on culture by establishing new expectations for food and the companies that make it. It is our privilege to be at the heart of this dynamic with a portfolio that appeals to each generation of people and pets and is found in 90 percent of U.S. homes and countless restaurants. This includes a mix of iconic brands consumers have always loved such as Folgers®, Jif® and Milk-Bone® and new favorites like Café Bustelo®, Smucker’s® Uncrustables®and Rachael Ray® Nutrish®. By continuing to immerse ourselves in consumer and pet parent preferences for food, how it’s purchased and how the companies that make it should operate, we will maintain the important role we play in their lives. This will allow us to continue growing our business and the positive impact we have on all of those who count on us. For more information, please visit jmsmucker.com.

The J. M. Smucker Company is the owner of all trademarks referenced herein, except for Rachael Ray® which is a trademark of Ray Marks II LLC.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/jif-brand-set-to-expand-product-innovation-and-convenience-with-jif-natural-squeeze-creamy-peanut-butter-spread-301200277.html

SOURCE The J.M. Smucker Co.

Certified Life Coach Takes Readers on a Journey to Self-Discovery in New Book

Pam Grewall showcases how to live a meaningful and productive life in ‘How to Help Yourself to Be Who You Want to Be’

SAINT PETERS, Mo., Jan. 04, 2021 (GLOBE NEWSWIRE) — Author Pam Grewall has released her debut book “How to Help Yourself to Be Who You Want to Be: A Simple Guide for Those Who Are Ready to Take Charge and Redirect Their Lives.” This inspiring text strives to enable teenagers, young adults and adults to take charge of their lives and allow for change and self-growth. Grewall will help readers understand that it is okay not to be perfect but that should not prevent them from improving.

Throughout the book, the author discusses how to reflect on options and make informed choices, come to understand oneself, take responsibility and be patient along the way. The book presents short stories, inspirational quotes and productive thinking questions that give a simple yet entertaining approach that readers of any age will understand. The author encourages readers that no matter what point they are at in life, it is never too late to change and look ahead.

As a certified life coach, I was inspired to write this book to help others live their best lives,” said Grewall. “When my children were growing up, I always had friends tell me that I should look into counseling because of the connection I had with children and young adults. Being able to talk to them from a counseling perspective encouraged me to continue helping others.”

“How to Help Yourself to Be Who You Want to Be” shows that despite the negativity and struggles that come with life, one can rise up and learn to accept themselves. Ultimately, Grewall offers readers guidance for living a meaningful life, making the changes to do so and that they are not alone in their journey towards self-acceptance. 

“How to Help Yourself to Be Who You Want to Be: A Simple Guide for Those Who Are Ready to Take Charge and Redirect Their Lives”

By Pam Grewall

ISBN: 9781532094033 (softcover); 9781532094019 (hardcover); 9781532094026 (electronic)

Available at the iUniverse Online Bookstore, Amazon and Barnes & Noble

About the author

Pam Grewall was a teacher, a business owner and worked in the nonprofit sector and entertainment industry. She was a speaker on a panel discussion about roles of religious organizations to prevent domestic violence. She enjoys reading, writing and helping others to be their best selves as a certified life coach.

iUniverse, an Author Solutions, LLC, self-publishing imprint, is the leading book marketing, editorial services, and supported self-publishing provider. iUniverse recognizes excellence in book publishing through the Star, Rising Star and Editor’s Choice designations—self-publishing’s only such awards program. iUniverse is headquartered in Bloomington, Indiana. For more information or to publish a book, please visit iuniverse.com or call 1-800-AUTHORS

Attachment



Meghan Bowman
LAVIDGE
480-306-6597
[email protected]

SMTC Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of SMTC Corporation Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – SMTX

SMTC Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of SMTC Corporation Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – SMTX

NEW YORK–(BUSINESS WIRE)–
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of SMTC Corporation (NASDAQ: SMTX) to an affiliate of H.I.G. Capital (“H.I.G.”) for $6.044 per share in cash is fair to SMTC shareholders.

Halper Sadeh encourages SMTC shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].

The investigation concerns whether SMTC and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for SMTC shareholders; (2) determine whether H.I.G. is underpaying for SMTC; and (3) disclose all material information necessary for SMTC shareholders to adequately assess and value the merger consideration. On behalf of SMTC shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

Halper Sadeh encourages SMTC shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

[email protected]

[email protected]

https://www.halpersadeh.com

KEYWORDS: United States North America Illinois New York

INDUSTRY KEYWORDS: Other Professional Services Professional Services Legal

MEDIA:

Logo
Logo

Here for Schools: Casey’s General Stores Teams up With LIFEWTR® to Support Local Schools

Here for Schools: Casey’s General Stores Teams up With LIFEWTR® to Support Local Schools

January giving campaign aids K-12 schools across Casey’s communities

ANKENY, Iowa–(BUSINESS WIRE)–
Today, Casey’s General Stores (Nasdaq: CASY) is kicking off a month-long giving campaign, in partnership with LIFEWTR, to support local schools in communities across its 16-state footprint.

Throughout January, Casey’s guests can round up their purchases to provide funding for projects and initiatives at K-12 public and nonprofit, private schools. In addition, $1 will be donated for every purchase of a LIFEWTR brand drink and a Mega Slice, up to $25,000 total.

“Teachers continue to demonstrate heroic efforts in the face of challenging school years, educating our children in schools, online and even sometimes both at the same time,” said Megan Elfers, Vice President of Marketing at Casey’s. “We are proud to do our part to support them, our schools and our communities when they need us most.”

“We are thrilled to partner with Casey’s to aid schools, particularly during these school years that saw a multitude of changes brought on by the pandemic,” said Guillermo Prieto, Director of Shopper Marketing, PepsiCo Beverage North America, Central Division. “This is a way for us to give back to our local communities while also reminding teachers that we have their backs as they navigate the waters of educating in this environment.”

Last fall, Casey’s announced its Cash for Classrooms grant program. Ranging from $1,000 to $50,000, the grants can be used for physical improvements, material needs, teacher support and community engagement initiatives. Grant recipients will be announced in March.

More information can be found at: www.caseys.com/community.

About Casey’s General Stores

Casey’s General Stores is a Fortune 500 company (Nasdaq: CASY) operating over 2,200 convenience stores in 16 states. Founded more than 50 years ago, the company has grown to become the fourth-largest convenience store retailer and the fifth-largest pizza chain in the United States. Casey’s provides freshly prepared foods, quality fuel and friendly service at every location. Guests can enjoy famous, made-from-scratch pizza, donuts, other assorted bakery items, and a wide selection of beverages and snacks. Learn more and order online at www.caseys.com, or in the mobile app.

About PepsiCo

PepsiCo products are enjoyed by consumers more than one billion times a day in more than 200 countries and territories around the world. PepsiCo generated more than $67 billion in net revenue in 2019, driven by a complementary food and beverage portfolio that includes Frito-Lay, Gatorade, Pepsi-Cola, Quaker and Tropicana. PepsiCo’s product portfolio includes a wide range of enjoyable foods and beverages, including 23 brands that generate more than $1 billion each in estimated annual retail sales.

Guiding PepsiCo is our vision to Be the Global Leader in Convenient Foods and Beverages by Winning with Purpose. “Winning with Purpose” reflects our ambition to win sustainably in the marketplace and embed purpose into all aspects of the business. For more information, visit www.pepsico.com.

Katie Petru

[email protected]

515.480.8503

KEYWORDS: Iowa United States North America

INDUSTRY KEYWORDS: Food/Beverage Retail Primary/Secondary Convenience Store Education

MEDIA:

Logo
Logo